Intron Retention of DDX39A Driven by SNRPD2 is a Crucial Splicing Axis for Oncogenic MYC/Spliceosome Program in Hepatocellular Carcinoma
Authors:
Open Access
- 17 July 2024
- journal article
- research article
- Published by Wiley in Advanced Science
- Vol. 11 (35) , e2403387
Abstract
RNA splicing is a dynamic molecular process in response to environmental stimuli and is strictly regulated by the spliceosome. Sm proteins, constituents of the spliceosome, are key components that mediate splicing reactions; however, their potential role in hepatocellular carcinoma (HCC) is poorly understood. In the study, SNRPD2 (PD2) is found to be the most highly upregulated Sm protein in HCC and to act as an oncogene. PD2 modulates DDX39A intron retention together with HNRNPL to sustain the DDX39A short variant (39A_S) expression. Mechanistically, 39A_S can mediate MYC mRNA nuclear export to maintain high MYC protein expression, while MYC in turn potentiates PD2 transcription. Importantly, digitoxin can directly interact with PD2 and has a notable cancer‐suppressive effect on HCC. The study reveals a novel mechanism by which DDX39A senses oncogenic MYC signaling and undergoes splicing via PD2 to form a positive feedback loop in HCC, which can be targeted by digitoxin.Keywords
Funding Information
- Innovative Research Group Project of the National Natural Science Foundation of China
- National Natural Science Foundation of China (82273953, 82072646, 82373888, 82372664)
- Youth Science Fund Project
- Fundamental Research Funds for the Central Universities (226‐2023‐00107)
- Natural Science Foundation of Zhejiang Province (LR21H160001, LY21H160043)
- Zhejiang Traditional Chinese Medicine Administration (GZY‐ZJ‐KJ‐24045)
This publication has 37 references indexed in Scilit:
- MYC regulates a pan-cancer network of co-expressed oncogenic splicing factorsCell Reports, 2022
- Cinobufagin inhibits proliferation of acute myeloid leukaemia cells by repressing c-Myc pathway-associated genesChemico-Biological Interactions, 2022
- DDX17‐regulated alternative splicing that produced an oncogenic isoform of PXN‐AS1 to promote HCC metastasisHepatology, 2021
- Oncogenic translation directs spliceosome dynamics revealing an integral role for SF3A3 in breast cancerMolecular Cell, 2021
- Spliceosome-targeted therapies trigger an antiviral immune response in triple-negative breast cancerCell, 2021
- The role of alternative splicing in cancer: From oncogenesis to drug resistanceDrug Resistance Updates, 2020
- c‐Myc‐mediated SNRPB upregulation functions as an oncogene in hepatocellular carcinomaCell Biology International, 2020
- Identification of important long non-coding RNAs and highly recurrent aberrant alternative splicing events in hepatocellular carcinoma through integrative analysis of multiple RNA-Seq datasetsMolecular Genetics and Genomics, 2015
- Real-time analysis of the effects of toxic, therapeutic and sub-therapeutic concentrations of digitoxin on lung cancer cellsBiosensors and Bioelectronics, 2014
- Digitoxin Inhibits the Growth of Cancer Cell Lines at Concentrations Commonly Found in Cardiac PatientsJournal of Natural Products, 2005